nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—chronic obstructive pulmonary disease	0.655	1	CbGaD
Triamterene—SCNN1G—sweat—chronic obstructive pulmonary disease	0.0808	0.547	CbGeAlD
Triamterene—SCNN1D—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.00932	0.0759	CbGpPWpGaD
Triamterene—SCNN1B—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.00932	0.0759	CbGpPWpGaD
Triamterene—SCNN1A—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.00932	0.0759	CbGpPWpGaD
Triamterene—SCNN1G—Stimuli-sensing channels—TRPV4—chronic obstructive pulmonary disease	0.00932	0.0759	CbGpPWpGaD
Triamterene—SCNN1D—respiratory system—chronic obstructive pulmonary disease	0.00725	0.0492	CbGeAlD
Triamterene—SCNN1G—respiratory system—chronic obstructive pulmonary disease	0.00725	0.0492	CbGeAlD
Triamterene—SCNN1D—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00682	0.0555	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00682	0.0555	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00682	0.0555	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00682	0.0555	CbGpPWpGaD
Triamterene—SCNN1B—respiratory system—chronic obstructive pulmonary disease	0.00613	0.0415	CbGeAlD
Triamterene—SCNN1D—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00608	0.0495	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00608	0.0495	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00608	0.0495	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00608	0.0495	CbGpPWpGaD
Triamterene—SCNN1G—bronchus—chronic obstructive pulmonary disease	0.00597	0.0405	CbGeAlD
Triamterene—SCNN1A—respiratory system—chronic obstructive pulmonary disease	0.00566	0.0384	CbGeAlD
Triamterene—SCNN1B—bronchus—chronic obstructive pulmonary disease	0.00504	0.0342	CbGeAlD
Triamterene—SCNN1A—bronchus—chronic obstructive pulmonary disease	0.00466	0.0316	CbGeAlD
Triamterene—SCNN1B—trachea—chronic obstructive pulmonary disease	0.00453	0.0307	CbGeAlD
Triamterene—SCNN1A—trachea—chronic obstructive pulmonary disease	0.00418	0.0284	CbGeAlD
Triamterene—SCNN1G—lung—chronic obstructive pulmonary disease	0.00385	0.0261	CbGeAlD
Triamterene—SCNN1D—lung—chronic obstructive pulmonary disease	0.00385	0.0261	CbGeAlD
Triamterene—SCNN1B—lung—chronic obstructive pulmonary disease	0.00325	0.0221	CbGeAlD
Triamterene—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00309	0.0412	CcSEcCtD
Triamterene—Calculus of kidney—Arformoterol—chronic obstructive pulmonary disease	0.00304	0.0406	CcSEcCtD
Triamterene—Calculus of kidney—Formoterol—chronic obstructive pulmonary disease	0.00304	0.0406	CcSEcCtD
Triamterene—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00301	0.0245	CbGpPWpGaD
Triamterene—SCNN1A—lung—chronic obstructive pulmonary disease	0.00301	0.0204	CbGeAlD
Triamterene—Nephrolithiasis—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.0331	CcSEcCtD
Triamterene—Nephrolithiasis—Formoterol—chronic obstructive pulmonary disease	0.00248	0.0331	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00237	0.0193	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00237	0.0193	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00237	0.0193	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00237	0.0193	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00212	0.0172	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00212	0.0172	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00212	0.0172	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00212	0.0172	CbGpPWpGaD
Triamterene—Hyperkalaemia—Formoterol—chronic obstructive pulmonary disease	0.00196	0.0261	CcSEcCtD
Triamterene—Hyperkalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00196	0.0261	CcSEcCtD
Triamterene—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.0231	CcSEcCtD
Triamterene—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00136	0.00922	CbGeAlD
Triamterene—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.0176	CcSEcCtD
Triamterene—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00132	0.0176	CcSEcCtD
Triamterene—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.0166	CcSEcCtD
Triamterene—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00121	0.0161	CcSEcCtD
Triamterene—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00106	0.0142	CcSEcCtD
Triamterene—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.0138	CcSEcCtD
Triamterene—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.0137	CcSEcCtD
Triamterene—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.001	0.0134	CcSEcCtD
Triamterene—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000958	0.0128	CcSEcCtD
Triamterene—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000958	0.0078	CbGpPWpGaD
Triamterene—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000934	0.0125	CcSEcCtD
Triamterene—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000926	0.0124	CcSEcCtD
Triamterene—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000898	0.012	CcSEcCtD
Triamterene—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00089	0.0119	CcSEcCtD
Triamterene—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000883	0.0118	CcSEcCtD
Triamterene—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000882	0.0118	CcSEcCtD
Triamterene—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000877	0.0117	CcSEcCtD
Triamterene—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000832	0.0111	CcSEcCtD
Triamterene—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000816	0.00664	CbGpPWpGaD
Triamterene—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000743	0.00605	CbGpPWpGaD
Triamterene—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000725	0.00967	CcSEcCtD
Triamterene—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000725	0.00967	CcSEcCtD
Triamterene—CYP1A2—lung—chronic obstructive pulmonary disease	0.000722	0.00489	CbGeAlD
Triamterene—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000711	0.00948	CcSEcCtD
Triamterene—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000711	0.00948	CcSEcCtD
Triamterene—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000696	0.00929	CcSEcCtD
Triamterene—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000688	0.00918	CcSEcCtD
Triamterene—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00913	CcSEcCtD
Triamterene—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000682	0.00909	CcSEcCtD
Triamterene—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000671	0.00895	CcSEcCtD
Triamterene—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000649	0.00866	CcSEcCtD
Triamterene—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000639	0.00852	CcSEcCtD
Triamterene—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000618	0.00824	CcSEcCtD
Triamterene—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000613	0.00817	CcSEcCtD
Triamterene—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000613	0.00817	CcSEcCtD
Triamterene—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.0006	0.00801	CcSEcCtD
Triamterene—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000594	0.00792	CcSEcCtD
Triamterene—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000589	0.00785	CcSEcCtD
Triamterene—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000588	0.00785	CcSEcCtD
Triamterene—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000585	0.0078	CcSEcCtD
Triamterene—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000582	0.00777	CcSEcCtD
Triamterene—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000579	0.00772	CcSEcCtD
Triamterene—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00056	0.00747	CcSEcCtD
Triamterene—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000555	0.00741	CcSEcCtD
Triamterene—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000555	0.0074	CcSEcCtD
Triamterene—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000555	0.0074	CcSEcCtD
Triamterene—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000553	0.00451	CbGpPWpGaD
Triamterene—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000552	0.00736	CcSEcCtD
Triamterene—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000524	0.00699	CcSEcCtD
Triamterene—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.00699	CcSEcCtD
Triamterene—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000523	0.00698	CcSEcCtD
Triamterene—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000518	0.00691	CcSEcCtD
Triamterene—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000513	0.00684	CcSEcCtD
Triamterene—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.0068	CcSEcCtD
Triamterene—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00051	0.0068	CcSEcCtD
Triamterene—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000499	0.00666	CcSEcCtD
Triamterene—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.0066	CcSEcCtD
Triamterene—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00649	CcSEcCtD
Triamterene—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00649	CcSEcCtD
Triamterene—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00642	CcSEcCtD
Triamterene—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00635	CcSEcCtD
Triamterene—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.00627	CcSEcCtD
Triamterene—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00047	0.00627	CcSEcCtD
Triamterene—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000469	0.00382	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000466	0.00379	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000466	0.00379	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000466	0.00379	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000466	0.00379	CbGpPWpGaD
Triamterene—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00614	CcSEcCtD
Triamterene—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00613	CcSEcCtD
Triamterene—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00603	CcSEcCtD
Triamterene—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00603	CcSEcCtD
Triamterene—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00045	0.00366	CbGpPWpGaD
Triamterene—Rash—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00598	CcSEcCtD
Triamterene—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00598	CcSEcCtD
Triamterene—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00597	CcSEcCtD
Triamterene—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00597	CcSEcCtD
Triamterene—Headache—Formoterol—chronic obstructive pulmonary disease	0.000445	0.00594	CcSEcCtD
Triamterene—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000445	0.00594	CcSEcCtD
Triamterene—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00592	CcSEcCtD
Triamterene—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000443	0.0059	CcSEcCtD
Triamterene—Rash—Montelukast—chronic obstructive pulmonary disease	0.000439	0.00586	CcSEcCtD
Triamterene—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000439	0.00585	CcSEcCtD
Triamterene—Headache—Montelukast—chronic obstructive pulmonary disease	0.000436	0.00582	CcSEcCtD
Triamterene—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00569	CcSEcCtD
Triamterene—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000427	0.00347	CbGpPWpGaD
Triamterene—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00564	CcSEcCtD
Triamterene—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00564	CcSEcCtD
Triamterene—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00563	CcSEcCtD
Triamterene—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00563	CcSEcCtD
Triamterene—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00042	0.00561	CcSEcCtD
Triamterene—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000413	0.00552	CcSEcCtD
Triamterene—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00532	CcSEcCtD
Triamterene—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000392	0.00319	CbGpPWpGaD
Triamterene—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000385	0.00513	CcSEcCtD
Triamterene—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000377	0.00307	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.00033	0.00268	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000311	0.00253	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000291	0.00237	CbGpPWpGaD
Triamterene—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.00378	CcSEcCtD
Triamterene—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00028	0.00373	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00028	0.00228	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00028	0.00228	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00028	0.00228	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00028	0.00228	CbGpPWpGaD
Triamterene—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.0034	CcSEcCtD
Triamterene—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00324	CcSEcCtD
Triamterene—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.00323	CcSEcCtD
Triamterene—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000241	0.00322	CcSEcCtD
Triamterene—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.00322	CcSEcCtD
Triamterene—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000229	0.00187	CbGpPWpGaD
Triamterene—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00305	CcSEcCtD
Triamterene—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00275	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000201	0.00164	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000201	0.00164	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000201	0.00164	CbGpPWpGaD
Triamterene—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00268	CcSEcCtD
Triamterene—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000198	0.00162	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000196	0.0016	CbGpPWpGaD
Triamterene—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00255	CcSEcCtD
Triamterene—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00153	CbGpPWpGaD
Triamterene—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00247	CcSEcCtD
Triamterene—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00237	CcSEcCtD
Triamterene—Rash—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00235	CcSEcCtD
Triamterene—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00235	CcSEcCtD
Triamterene—Headache—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00234	CcSEcCtD
Triamterene—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00222	CcSEcCtD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00133	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.00131	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000138	0.00112	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.00107	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000126	0.00103	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000116	0.000945	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000115	0.000934	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000111	0.000907	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	9.43e-05	0.000768	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	8.66e-05	0.000705	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	8.49e-05	0.000691	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	8.49e-05	0.000691	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.16e-05	0.000664	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	8.08e-05	0.000658	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	8.08e-05	0.000658	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.05e-05	0.000655	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.94e-05	0.000646	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.39e-05	0.000602	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.29e-05	0.000594	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.01e-05	0.000571	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.91e-05	0.000563	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	5.64e-05	0.000459	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.02e-05	0.000327	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.74e-05	0.000304	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	3.63e-05	0.000296	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.38e-05	0.000275	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.69e-05	0.000219	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.99e-05	0.000162	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.96e-05	0.00016	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.83e-05	0.000149	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.79e-05	0.000146	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.000112	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.36e-05	0.000111	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	9.76e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	8.15e-06	6.64e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.8e-06	6.35e-05	CbGpPWpGaD
